BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31747379)

  • 21. Thyroid V
    Zhou L; Chen J; Shen W; Chen ZL; Huang S; Tao CJ; Chen M; Yu ZH; Chen YY
    Radiat Oncol; 2020 Mar; 15(1):68. PubMed ID: 32293496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypothyroidism after 3-dimensional conformal radiotherapy and intensity-modulated radiotherapy for head and neck cancers: prospective data from 2 randomized controlled trials.
    Murthy V; Narang K; Ghosh-Laskar S; Gupta T; Budrukkar A; Agrawal JP
    Head Neck; 2014 Nov; 36(11):1573-80. PubMed ID: 23996654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dose-volume predictors of post-radiation primary hypothyroidism in head and neck cancer: A systematic review.
    Chow JCH; Cheung KM; Cheung GTC; Tam AHP; Lui JCF; Lee FKH; Au KH; Ng WT; Lee AWM; Yiu HHY
    Clin Transl Radiat Oncol; 2022 Mar; 33():83-92. PubMed ID: 35128087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid V30 predicts radiation-induced hypothyroidism in patients treated with sequential chemo-radiotherapy for Hodgkin's lymphoma.
    Cella L; Conson M; Caterino M; De Rosa N; Liuzzi R; Picardi M; Grimaldi F; Solla R; Farella A; Salvatore M; Pacelli R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1802-8. PubMed ID: 21514076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. External validation of a normal tissue complication probability model for radiation-induced hypothyroidism in an independent cohort.
    Rønjom MF; Brink C; Bentzen SM; Hegedüs L; Overgaard J; Petersen JB; Primdahl H; Johansen J
    Acta Oncol; 2015; 54(9):1301-9. PubMed ID: 26248025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypothyroidism after external radiotherapy for head and neck cancer.
    Tell R; Sjödin H; Lundell G; Lewin F; Lewensohn R
    Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):303-8. PubMed ID: 9308932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypothyroidism in patients treated with radiotherapy for head and neck carcinoma: standardised long-term follow-up study.
    Alba JR; Basterra J; Ferrer JC; Santonja F; Zapater E
    J Laryngol Otol; 2016 May; 130(5):478-81. PubMed ID: 26975210
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of radiotherapy response with a 5-microRNA signature-based nomogram in head and neck squamous cell carcinoma.
    Chen L; Wen Y; Zhang J; Sun W; Lui VWY; Wei Y; Chen F; Wen W
    Cancer Med; 2018 Mar; 7(3):726-735. PubMed ID: 29473326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid disorders in patients treated with radiotherapy for head-and-neck cancer: a retrospective analysis of seventy-three patients.
    Alterio D; Jereczek-Fossa BA; Franchi B; D'Onofrio A; Piazzi V; Rondi E; Ciocca M; Gibelli B; Grosso E; Tradati N; Mariani L; Boboc GI; Orecchia R
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):144-50. PubMed ID: 17084554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiation-induced hypothyroidism in patients of oral squamous cell carcinoma: A retrospective analysis of 195 patients.
    Jain PV; Das A; Manikantan K; Sharan R; Mallick I; Chatterjee S; Arun P
    Indian J Cancer; 2022; 59(4):480-484. PubMed ID: 33753621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid function should be monitored following radiotherapy to the low neck.
    Garcia-Serra A; Amdur RJ; Morris CG; Mazzaferri E; Mendenhall WM
    Am J Clin Oncol; 2005 Jun; 28(3):255-8. PubMed ID: 15923797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
    de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
    Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-radiation primary hypothyroidism in patients with head and neck cancer: External validation of thyroid gland dose-volume constraints with long-term endocrine outcomes.
    Chow JCH; Lui JCF; Cheung KM; Tam AHP; Lam MHC; Yuen TYS; Lee FKH; Leung AKC; Au KH; Ng WT; Lee AWM; Kwan CK; Yiu HHY
    Radiother Oncol; 2022 Dec; 177():105-110. PubMed ID: 36336109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.
    Levy DA; Li H; Sterba KR; Hughes-Halbert C; Warren GW; Nussenbaum B; Alberg AJ; Day TA; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 May; 146(5):455-464. PubMed ID: 32239201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck.
    Colevas AD; Read R; Thornhill J; Adak S; Tishler R; Busse P; Li Y; Posner M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):599-604. PubMed ID: 11597798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal tissue complication probability modeling of radiation-induced hypothyroidism after head-and-neck radiation therapy.
    Bakhshandeh M; Hashemi B; Mahdavi SR; Nikoofar A; Vasheghani M; Kazemnejad A
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):514-21. PubMed ID: 22583606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radiation-induced hypothyroidism in head and neck cancer patients: a systematic review.
    Boomsma MJ; Bijl HP; Langendijk JA
    Radiother Oncol; 2011 Apr; 99(1):1-5. PubMed ID: 21459468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of External Beam Radiotherapy Dose with Subclinical Hypothyroidism in Patients undergoing Adjuvant Neck Radiation after Surgery for Squamous Cell Carcinoma of Head and Neck.
    Uddin N; Iqbal M; Hashmi H
    J Coll Physicians Surg Pak; 2021 Mar; 31(3):359-360. PubMed ID: 33775035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors.
    Wang C; Hou Y; Wang L; Yang Y; Li X
    BMC Cancer; 2024 Jan; 24(1):5. PubMed ID: 38166748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypothyroidism as a consequence of intensity-modulated radiotherapy with concurrent taxane-based chemotherapy for locally advanced head-and-neck cancer.
    Diaz R; Jaboin JJ; Morales-Paliza M; Koehler E; Phillips JG; Stinson S; Gilbert J; Chung CH; Murphy BA; Yarbrough WG; Murphy PB; Shyr Y; Cmelak AJ
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):468-76. PubMed ID: 19577867
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.